The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Resistance to anti-PD-1/anti-PD-L1: GB1211 reverses galectin-3 induced blockade of pembrolizumab and atezolizumab binding to PD-1/PD-L1.
 
Joseph Mabbitt
Employment - Galecto
Patents, Royalties, Other Intellectual Property - Tusk Therapeutics
 
James A. Roper
Employment - Galecto
Stock and Other Ownership Interests - Galecto; GlaxoSmithKline
 
Robert John Slack
Employment - Galecto
Stock and Other Ownership Interests - Galecto; GlaxoSmithKline